School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, 950 Atlantic Dr NW, Atlanta, GA, 30332-2000, USA.
BioEngineering Program, Georgia Institute of Technology, USA.
Nanoscale. 2024 Aug 22;16(33):15465-15480. doi: 10.1039/d4nr02093f.
While the cellular cytosol and organelles contain attractive targets for disease treatments, it remains a challenge to deliver therapeutic biomacromolecules to these sites. This is due to the selective permeability of the plasma and endosomal membranes, especially for large and hydrophilic therapeutic cargos such as proteins and nucleic acids. In response, many different delivery systems and molecules have been devised to help therapeutics cross these barriers to reach cytosolic targets. Among them are peptide and protein-based systems, which have several advantages over other natural and synthetic materials including their ability to interact with cell membranes. In this review, we will describe recent advances and current challenges of peptide and protein strategies that leverage cell membrane association and modulation to enable cytosolic delivery of biomacromolecule cargo. The approaches covered here include peptides and proteins derived from or inspired by natural sequences as well as those designed for delivery function.
虽然细胞胞质溶胶和细胞器含有有吸引力的疾病治疗靶点,但将治疗性生物大分子递送到这些部位仍然是一个挑战。这是由于质膜和内体膜的选择性通透性,特别是对于蛋白质和核酸等大的亲水性治疗性有效载荷。为此,已经设计了许多不同的递送系统和分子来帮助治疗剂穿过这些屏障到达胞质溶胶靶点。其中包括基于肽和蛋白质的系统,与其他天然和合成材料相比,它们具有几个优点,包括与细胞膜相互作用的能力。在这篇综述中,我们将描述利用细胞膜关联和调节来实现生物大分子有效载荷胞质递送的肽和蛋白质策略的最新进展和当前挑战。这里涵盖的方法包括源自天然序列或受其启发的肽和蛋白质,以及为递送来设计的肽和蛋白质。